These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 34619680)

  • 1. The Regional Specificity of Mucosa-Associated Microbiota in Patients with Distal Colorectal Cancer.
    Kono Y; Inoue R; Teratani T; Tojo M; Kumagai Y; Morishima S; Koinuma K; Lefor AK; Kitayama J; Sata N; Horie H
    Digestion; 2022; 103(2):141-149. PubMed ID: 34619680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microbial dynamics with CRC progression: a study of the mucosal microbiota at multiple sites in cancers, adenomatous polyps, and healthy controls.
    Senthakumaran T; Moen AEF; Tannæs TM; Endres A; Brackmann SA; Rounge TB; Bemanian V; Tunsjø HS
    Eur J Clin Microbiol Infect Dis; 2023 Mar; 42(3):305-322. PubMed ID: 36703031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Network Analysis of Gut Microbiota Including Fusobacterium and Oral Origin Bacteria and Their Distribution on Tumor Surface, Normal Mucosa, and in Feces in Patients with Colorectal Cancer.
    Ohashi A; Yamamura T; Nakamura M; Maeda K; Sawada T; Ishikawa E; Yamamoto K; Ishikawa T; Kakushima N; Furukawa K; Ohno E; Honda T; Kawashima H; Ishigami M; Fujishiro M
    Digestion; 2022; 103(6):451-461. PubMed ID: 36349755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enrichment of Prevotella intermedia in human colorectal cancer and its additive effects with Fusobacterium nucleatum on the malignant transformation of colorectal adenomas.
    Lo CH; Wu DC; Jao SW; Wu CC; Lin CY; Chuang CH; Lin YB; Chen CH; Chen YT; Chen JH; Hsiao KH; Chen YJ; Chen YT; Wang JY; Li LH
    J Biomed Sci; 2022 Oct; 29(1):88. PubMed ID: 36303164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Berberine may rescue Fusobacterium nucleatum-induced colorectal tumorigenesis by modulating the tumor microenvironment.
    Yu YN; Yu TC; Zhao HJ; Sun TT; Chen HM; Chen HY; An HF; Weng YR; Yu J; Li M; Qin WX; Ma X; Shen N; Hong J; Fang JY
    Oncotarget; 2015 Oct; 6(31):32013-26. PubMed ID: 26397137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a bacteriocin-producing
    Lawrence GW; McCarthy N; Walsh CJ; Kunyoshi TM; Lawton EM; O'Connor PM; Begley M; Cotter PD; Guinane CM
    Gut Microbes; 2022; 14(1):2100203. PubMed ID: 35877697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fusobacterium nucleatum as a prognostic marker of colorectal cancer in a Japanese population.
    Yamaoka Y; Suehiro Y; Hashimoto S; Hoshida T; Fujimoto M; Watanabe M; Imanaga D; Sakai K; Matsumoto T; Nishioka M; Takami T; Suzuki N; Hazama S; Nagano H; Sakaida I; Yamasaki T
    J Gastroenterol; 2018 Apr; 53(4):517-524. PubMed ID: 28823057
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Ye X; Wang R; Bhattacharya R; Boulbes DR; Fan F; Xia L; Adoni H; Ajami NJ; Wong MC; Smith DP; Petrosino JF; Venable S; Qiao W; Baladandayuthapani V; Maru D; Ellis LM
    Cancer Prev Res (Phila); 2017 Jul; 10(7):398-409. PubMed ID: 28483840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parvimonas micra forms a distinct bacterial network with oral pathobionts in colorectal cancer patients.
    Löwenmark T; Köhn L; Kellgren T; Rosenbaum W; Bronnec V; Löfgren-Burström A; Zingmark C; Larsson P; Dahlberg M; Schroeder BO; Wai SN; Ljuslinder I; Edin S; Palmqvist R
    J Transl Med; 2024 Oct; 22(1):947. PubMed ID: 39420333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parvimonas micra, Peptostreptococcus stomatis, Fusobacterium nucleatum and Akkermansia muciniphila as a four-bacteria biomarker panel of colorectal cancer.
    Osman MA; Neoh HM; Ab Mutalib NS; Chin SF; Mazlan L; Raja Ali RA; Zakaria AD; Ngiu CS; Ang MY; Jamal R
    Sci Rep; 2021 Feb; 11(1):2925. PubMed ID: 33536501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Oral Microbiota May Have Influence on Oral Cancer.
    Zhang L; Liu Y; Zheng HJ; Zhang CP
    Front Cell Infect Microbiol; 2019; 9():476. PubMed ID: 32010645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut microbiota signatures in tissues of the colorectal polyp and normal colorectal mucosa, and faeces.
    Zhong X; Wang Y; Xu J; Cao H; Zhang F; Wang X
    Front Cell Infect Microbiol; 2022; 12():1054808. PubMed ID: 36704106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21.
    Yang Y; Weng W; Peng J; Hong L; Yang L; Toiyama Y; Gao R; Liu M; Yin M; Pan C; Li H; Guo B; Zhu Q; Wei Q; Moyer MP; Wang P; Cai S; Goel A; Qin H; Ma Y
    Gastroenterology; 2017 Mar; 152(4):851-866.e24. PubMed ID: 27876571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between
    Proença MA; Biselli JM; Succi M; Severino FE; Berardinelli GN; Caetano A; Reis RM; Hughes DJ; Silva AE
    World J Gastroenterol; 2018 Dec; 24(47):5351-5365. PubMed ID: 30598580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbiota profile is different for early and invasive colorectal cancer and is consistent throughout the colon.
    Zorron Cheng Tao Pu L; Yamamoto K; Honda T; Nakamura M; Yamamura T; Hattori S; Burt AD; Singh R; Hirooka Y; Fujishiro M
    J Gastroenterol Hepatol; 2020 Mar; 35(3):433-437. PubMed ID: 31609493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of preoperative antibiotics and other variables on integrated microbiome-host transcriptomic data generated from colorectal cancer resections.
    Malik SA; Zhu C; Li J; LaComb JF; Denoya PI; Kravets I; Miller JD; Yang J; Kramer M; McCombie WR; Robertson CE; Frank DN; Li E
    World J Gastroenterol; 2021 Apr; 27(14):1465-1482. PubMed ID: 33911468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of Mucosa-Associated Microbiota in Matched Cancer and Non-neoplastic Mucosa From Patients With Colorectal Cancer.
    Leung PHM; Subramanya R; Mou Q; Lee KT; Islam F; Gopalan V; Lu CT; Lam AK
    Front Microbiol; 2019; 10():1317. PubMed ID: 31244818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced Abundance of
    Ota G; Inoue R; Saito A; Kono Y; Kitayama J; Sata N; Horie H
    J Anus Rectum Colon; 2024; 8(3):235-245. PubMed ID: 39086872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The presence of bacteria varies between colorectal adenocarcinomas, precursor lesions and non-malignant tissue.
    Bundgaard-Nielsen C; Baandrup UT; Nielsen LP; Sørensen S
    BMC Cancer; 2019 Apr; 19(1):399. PubMed ID: 31035942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut Microbiota Signatures in Tumor, Para-Cancerous, Normal Mucosa, and Feces in Colorectal Cancer Patients.
    Li Y; Cao H; Fei B; Gao Q; Yi W; Han W; Bao C; Xu J; Zhao W; Zhang F
    Front Cell Dev Biol; 2022; 10():916961. PubMed ID: 35721506
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.